A simplified approach to ovarian lesions based on the O-RADS US risk stratification and management system

Mohamadian, Alireza; Bayani, Leila; Katouli, Fatemeh Shakki

doi:10.14366/usg.22037

Cited by 3 publications

(2 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…O-RADS 0 means that the evaluation is incomplete; O-RADS 1 is used for normal ovaries or a physiological cyst with 0% probability of malignancy; O-RADS 2 (<1% malignancy) is set for an almost certainly benign lesion; O-RADS 3 is used for lesions with low risk of malignancy (1–9%); O-RADS 4 indicates lesions with an intermediate risk of malignancy (10–49%), whereas O-RADS 5 is associated with a high risk of malignancy (≥50%). To date, different flowcharts have been described to simplify its use [ 17 ].…”

Section: Introductionmentioning

confidence: 99%

Comparison of Ultrasound Scores in Differentiating between Benign and Malignant Adnexal Masses

et al. 2023

View full text Add to dashboard Cite

Subjective ultrasound assessment by an expert examiner is meant to be the best option for the differentiation between benign and malignant adnexal masses. Different ultrasound scores can help in the classification, but whether one of them is significantly better than others is still a matter of debate. The main aim of this work is to compare the diagnostic performance of some of these scores in the evaluation of adnexal masses in the same set of patients. This is a retrospective study of a consecutive series of women diagnosed as having a persistent adnexal mass and managed surgically. Ultrasound characteristics were analyzed according to IOTA criteria. Masses were classified according to the subjective impression of the sonographer and other ultrasound scores (IOTA simple rules -SR-, IOTA simple rules risk assessment -SRRA-, O-RADS classification, and ADNEX model -with and without CA125 value-). A total of 122 women were included. Sixty-two women were postmenopausal (50.8%). Eighty-one women had a benign mass (66.4%), and 41 (33.6%) had a malignant tumor. The sensitivity of subjective assessment, IOTA SR, IOTA SRRA, and ADNEX model with or without CA125 and O-RADS was 87.8%, 66.7%, 78.1%, 95.1%, 87.8%, and 90.2%, respectively. The specificity for these approaches was 69.1%, 89.2%, 72.8%, 74.1%, 67.9%, and 60.5%, respectively. All methods with similar AUC (0.81, 0.78, 0.80, 0.88, 0.84, and 0.75, respectively). We concluded that IOTA SR, IOTA SRRA, and ADNEX models with or without CA125 and O-RADS can help in the differentiation of benign and malignant masses, and their performance is similar to the subjective assessment of an experienced sonographer.

show abstract

Section: Introductionmentioning

confidence: 99%

Comparison of Ultrasound Scores in Differentiating between Benign and Malignant Adnexal Masses

et al. 2023

View full text Add to dashboard Cite

show abstract

“…Compared to the risk-oriented approach to ovarian lesions presented in recent guideline tables, a lesion-oriented flowchart would be more practical for radiologists [ 4 5 ]. Therefore, we summarized the findings of the guidelines in the form of an algorithm to explain how to approach ovarian lesions simply ( Fig.…”

mentioning

confidence: 99%

Simplified Approach for Ovarian-Adnexal Reporting and Data System MRI Risk Stratification System

Mohamadian

Moradi

2022

Korean J Radiol

View full text Add to dashboard Cite

O-RADS US v2022: An Update from the American College of Radiology’s Ovarian-Adnexal Reporting and Data System US Committee

Strachowski,

Jha,

Phillips

et al. 2023

Radiology

View full text Add to dashboard Cite

A simplified approach to ovarian lesions based on the O-RADS US risk stratification and management system

Cited by 3 publications

References 6 publications

Comparison of Ultrasound Scores in Differentiating between Benign and Malignant Adnexal Masses

Comparison of Ultrasound Scores in Differentiating between Benign and Malignant Adnexal Masses

Simplified Approach for Ovarian-Adnexal Reporting and Data System MRI Risk Stratification System

O-RADS US v2022: An Update from the American College of Radiology’s Ovarian-Adnexal Reporting and Data System US Committee

Contact Info

Product

Resources

About